Gudmar Lundqvist

Medical treatment and long‐term survival in a prospective study of 84 patients with endocrine pancreatic tumors

E. Wilander, B. Skogseid, K. Öberg, 1990, Cancer.

Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.

B. Skogseid, M. Stridsberg, D. Granberg, 1999, The Journal of clinical endocrinology and metabolism.

SCREENING FOR MULTIPLE ENDOCRINE NEOPLASIA SYNDROME (TYPE 1) IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

S. Ljunghall, M. Palmér, L. Wide, 1984, Clinical endocrinology.

The effects of endogenous hypergastrinemia and hypogastrinemia on the exocrine and endocrine rat pancreas.

E. Wilander, L. Grimelius, P. Heitz, 1979, Upsala journal of medical sciences.

A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.

U. Hellman, C. Wernstedt, E. Wilander, 1990, Acta endocrinologica.

Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states.

H. Lithell, B. Vessby, K. Hellsing, 1978, Atherosclerosis.

Hypersecretion of calcitonin in patients with the Verner-Morrison syndrome.

J. Fahrenkrug, L. Grimelius, K. Oberg, 1981, Scandinavian journal of gastroenterology.

Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments.

U. Hellman, E. Wilander, M. Stridsberg, 1993, The Journal of endocrinology.